Hardy Isabelle, Gagnon Anthony, Croft Erika-Kate, Tremblay Luc, Lebel Réjean, Roy-Lacroix Marie-Ève, Takser Larissa, Ouellet Annie, Gris Denis
Université de Sherbrooke, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, 3001, 12th Avenue North, Sherbrooke (Quebec) J1H 5N4, Canada; Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke, 3001, 12th Avenue North, Sherbrooke (Quebec) J1H 5N4, Canada.
Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke, 3001, 12th Avenue North, Sherbrooke (Quebec) J1H 5N4, Canada; Université de Sherbrooke, Department of Pediatrics, 3001, 12th Avenue North, Sherbrooke (Quebec) J1H 5N4, Canada.
Neurotoxicol Teratol. 2025 Jul-Aug;110:107523. doi: 10.1016/j.ntt.2025.107523. Epub 2025 Jul 11.
The safety of antenatal corticosteroid administration during the late preterm period is currently questioned. This experimental study conducted in a CD-1 mouse model aimed to determine if exposure to betamethasone in the late preterm period 1) induces behavioral changes in adulthood and 2) alters cerebral anatomy. In the prenatal group, four gravid mice were randomly assigned to receive 0.1 mg of betamethasone (around 1.82 mg/kg based on an average body weight of 55 g) or an equivalent volume of phosphate buffered saline (PBS) on gestation day 18, and yielded a total of 43 pups. This model was selected to test the impact of cumulative exposure to exogenous and endogenous steroids. In the postnatal group, six gravid mice yielded a total of 69 pups which were randomly assigned to receive betamethasone or PBS. Pups in the intervention group received 0.03 mg of betamethasone subcutaneously on postnatal day 5, at which time mouse brain development is equivalent to that of humans at 34-36 weeks' gestation. To evaluate objective 1, pups were subjected to behavioral tests on postnatal days 21-50. On postnatal day 60, structural magnetic resonance imaging (MRI) was performed to assess objective 2. Outcomes were compared between treatment groups using linear mixed models including random effects for litter and a fixed term for the interaction of treatment and sex. We used a statistical significance threshold of p < 0.05. Male mice exposed to betamethasone ante- or postnatally engaged in more social contact than those exposed to PBS (interaction of betamethasone and male sex: prenatal β = 0.09, 95 % CI (0.02, 0.17), p = 0.02; postnatal β = 0.08, 95 %CI (0.01, 0.14), p = 0.03), while female mice engaged in less social contact. MRI showed that male mice exposed to betamethasone prenatally had larger habenulas and smaller amygdala than those exposed to PBS (interaction of betamethasone and male sex: habenula β = 0.01, 95 %CI (0.004, 0.02), p = 0.01, amygdala β = -1.43, 95 %CI (-2.67, -0.21), p = 0.03), while female mice had larger amygdala and smaller habenulas. Postnatal exposure to betamethasone was associated with lower combined volume of the parietal cortex and hypothalamus (interaction of betamethasone and male sex: β = -0.32, 95 %CI (-0.58, -0.03), p = 0.04). No other significant differences in behavioral outcomes or brain volumes were identified. These results suggest that exposure to betamethasone in the late preterm period is associated with small but significant sex-specific disruptions of the limbic system, associated with social behavior disturbances.
目前,晚期早产期间使用产前皮质类固醇的安全性受到质疑。这项在CD-1小鼠模型上进行的实验研究旨在确定晚期早产期间暴露于倍他米松是否会:1)导致成年后的行为改变;2)改变大脑解剖结构。在产前组中,4只妊娠小鼠在妊娠第18天被随机分配接受0.1毫克倍他米松(基于平均体重55克,约为1.82毫克/千克)或等量的磷酸盐缓冲盐水(PBS),共产生43只幼崽。选择该模型来测试外源性和内源性类固醇累积暴露的影响。在产后组中,6只妊娠小鼠共产生69只幼崽,这些幼崽被随机分配接受倍他米松或PBS。干预组的幼崽在出生后第5天皮下注射0.03毫克倍他米松,此时小鼠大脑发育相当于人类妊娠34 - 36周时的发育阶段。为评估目标1,在出生后第21 - 50天对幼崽进行行为测试。在出生后第60天,进行结构磁共振成像(MRI)以评估目标2。使用线性混合模型比较治疗组之间的结果,该模型包括窝的随机效应以及治疗与性别的交互作用的固定项。我们使用p < 0.05作为统计学显著性阈值。产前或产后暴露于倍他米松的雄性小鼠比暴露于PBS的雄性小鼠有更多的社交接触(倍他米松与雄性的交互作用:产前β = 0.09,95%CI(0.02,0.17),p = 0.02;产后β = (0.01,0.14),p = 0.03),而雌性小鼠的社交接触较少。MRI显示,产前暴露于倍他米松的雄性小鼠比暴露于PBS的雄性小鼠有更大的缰核和更小的杏仁核(倍他米松与雄性的交互作用:缰核β = 0.01,95%CI(0.004,0.02),p = 0.01,杏仁核β = -1.43,95%CI(-2.67,-0.21),p = 0.03),而雌性小鼠有更大的杏仁核和更小的缰核。产后暴露于倍他米松与顶叶皮质和下丘脑的总体积较低有关(倍他米松与雄性的交互作用:β = -0.32,95%CI(-0.58,-0.03),p = 0.04)。在行为结果或脑容量方面未发现其他显著差异。这些结果表明,晚期早产期间暴露于倍他米松与边缘系统微小但显著的性别特异性破坏有关,并伴有社会行为障碍。